The present study extends these findings by demonstrating that flutamide upregulates miR-449a and miR-449b-5p in SKOV3 and Hey ovarian cancer cells (Fig. 3), leading to a marked reduction of AR expression at both the mRNA and protein levels (Fig. 5 and Suppl. The gene discussed is AR; the disease is ovarian carcinoma.